Latest immunotherapy news
Recurrence-Free Survival Longer With Nivolumab Than Ipilimumab in Melanoma
posted October 21st
by modernClinician Editorial Team
by modernClinician Editorial Team
Antithymocyte Globulin Cuts Loss of β-Cell Function in Type 1 Diabetes
posted September 29th
by modernClinician Editorial Team
by modernClinician Editorial Team
Stapokibart Found to Be Superior to Placebo for Severe Chronic Rhinosinusitis With Polyps
posted August 20th
by modernClinician Editorial Team
by modernClinician Editorial Team
High Response to PD-1 Therapy Seen in Unresectable Desmoplastic Melanoma
posted August 19th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Thymic Radiation Linked to Worse Outcomes in Patients With NSCLC 
Preoperative Chemo + Immunotherapy Combo Shrinks Head, Neck Cancer Tumors 
Cretostimogene Promising for High-Risk, Non-Muscle-Invasive Bladder Cancer 
Omalizumab, Multiallergen OIT Both Viable for Multifood Allergy Treatment Related Articles
Enfortumab Vedotin-Pembrolizumab More Effective for MIBC Than Cisplatin-Gemcitabine 
Indefinite-Duration Maintenance Therapy No Better Than Fixed-Duration Therapy in Multiple Myeloma 
Rituximab Noninferior to Ocrelizumab for Newly Diagnosed Relapsing MS 
Aglatimagene Besadenovec + Valacyclovir Ups DFS in Localized Prostate Cancer Monthly Specialist Briefings
Stay Connected
